Martin Mac Cheever

Dr. Cheever is currently the Principal Investigator of the NCI-funded Cancer Immunotherapy Trials Network (CITN) which has established a network of leading investigators to conduct early phase trials intended to demonstrate proof of concept. He is concurrently a Member of Fred Hutchinson Cancer Research Center (FHCRC). Dr. Cheever also has a decade of experience as a Professor of Medicine at the University of Washington and co-founded Corixa Corporation, to develop cancer vaccines, where he served as the Vice President of Clinical Research.